Free Trial

DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of "Moderate Buy" from Analysts

DocGo logo with Medical background

Key Points

  • DocGo Inc. has received an average rating of "Moderate Buy" from six brokerages, with three ratings for hold and three for buy.
  • The company's stock price objective has been adjusted by analysts, with a recent average target of $3.56, down from previous estimates.
  • DocGo reported an earnings loss of $0.09 per share for the last quarter, missing expectations, with revenues at $96.03 million compared to forecasts of $104.25 million.
  • Looking to export and analyze DocGo data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $3.56.

Several research analysts have issued reports on the stock. BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Canaccord Genuity Group reaffirmed a "hold" rating and set a $1.45 target price (down from $5.00) on shares of DocGo in a report on Monday, May 12th. Finally, Needham & Company LLC cut their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th.

Get Our Latest Analysis on DCGO

Hedge Funds Weigh In On DocGo

Hedge funds have recently made changes to their positions in the business. Jefferies Financial Group Inc. grew its position in DocGo by 6,874.1% during the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock worth $5,358,000 after acquiring an additional 2,000,356 shares during the last quarter. American Century Companies Inc. increased its position in DocGo by 175.5% in the 1st quarter. American Century Companies Inc. now owns 1,245,894 shares of the company's stock valued at $3,289,000 after acquiring an additional 793,640 shares in the last quarter. S Squared Technology LLC raised its stake in shares of DocGo by 36.8% in the first quarter. S Squared Technology LLC now owns 1,890,976 shares of the company's stock worth $4,992,000 after acquiring an additional 508,590 shares during the last quarter. P.A.W. Capital Corp grew its stake in shares of DocGo by 25.0% during the first quarter. P.A.W. Capital Corp now owns 2,000,000 shares of the company's stock valued at $5,280,000 after purchasing an additional 400,000 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of DocGo by 219.1% in the first quarter. AQR Capital Management LLC now owns 476,645 shares of the company's stock valued at $1,258,000 after purchasing an additional 327,269 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company's stock.

DocGo Price Performance

DocGo stock traded down $0.06 during midday trading on Monday, hitting $1.37. 195,024 shares of the stock were exchanged, compared to its average volume of 882,356. The company has a 50 day moving average price of $1.50 and a two-hundred day moving average price of $2.65. The firm has a market cap of $139.20 million, a P/E ratio of -68.25 and a beta of 0.97. DocGo has a 1 year low of $1.23 and a 1 year high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The business had revenue of $96.03 million for the quarter, compared to analysts' expectations of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. As a group, analysts predict that DocGo will post 0.25 EPS for the current year.

DocGo Company Profile

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines